Previous Next

Recent News

Access the latest information regarding our company, people, science, partnerships and opportunities.

Explore

For Investors


Rigvir Group is committed to partner with global industry and business leaders in the fight against oncological illness.

Explore

Since 2018 Rigvir Group has implemented functional changes to become a premium biotech company, focusing the resources on its production development and manufacturing capacity, providing the opportunity for global partnerships regarding product promotion and distribution.

About Rigvir Group

Representatives


Contact us to receive a consultation and/or information about oncolytic virotherapy with ECHO-7 medicine.

Contact Us